Baxter International reports third quarter sales increase

DEERFIELD - Baxter International Inc., a leading global medical products company, Thursday reported worldwide sales in the fiscal year third quarter totaled $2.97 billion, an increase of 4% - and 3% on an operational basis - compared to the prior-year period.

Operational sales in the third quarter exclude the impact of foreign currency exchange and the company's February acquisition of Seprafilm, the company said.

"Baxter's third-quarter performance reflects ongoing demand for our medically essential products as well as the company's agility and resilience amid a historic public health crisis," said José (Joe) E. Almeida, chairman and chief executive officer. "Our multiyear transformation has positioned us with the strength and adaptability to address today's unique challenges while continuing to identify opportunities to drive additional value for patients, clinicians, communities and shareholders."

Sales in the U.S. totaled $1.2 billion while international sales of $1.7 billion were reported for the quarter.